Phase II study of paclitaxel (Genaxol®) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)

Chih Hung Chen, Wen Cheng Chang, Meng Chin Lin, Jen Wen Hsu, Tsu Yi Chao, Thomas C.Y. Tsao

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of paclitaxel (Genaxol®) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science